193 related articles for article (PubMed ID: 12780409)
1. Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease.
Batioğlu F; Atmaca LS; Karabulut HG; Beyza Sayin D
Acta Ophthalmol Scand; 2003 Jun; 81(3):283-5. PubMed ID: 12780409
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
3. Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations.
Aras S; Yilmaz G; Alpas I; Baltaci V; Tayanç E; Aydin P
Eur J Ophthalmol; 2001; 11(4):351-5. PubMed ID: 11820306
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion.
Kalayci D; Gürgey A; Güven D; Parlak H; Hasiripi H
Acta Ophthalmol Scand; 1999 Dec; 77(6):622-4. PubMed ID: 10634550
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden mutation is associated with ocular involvement in Behçet disease.
Verity DH; Vaughan RW; Madanat W; Kondeatis E; Zureikat H; Fayyad F; Kanawati CA; Ayesh I; Stanford MR; Wallace GR
Am J Ophthalmol; 1999 Sep; 128(3):352-6. PubMed ID: 10511031
[TBL] [Abstract][Full Text] [Related]
6. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
Weger M; Renner W; Pinter O; Stanger O; Temmel W; Fellner P; Schmut O; Haas A
Eye (Lond); 2003 Aug; 17(6):731-4. PubMed ID: 12928685
[TBL] [Abstract][Full Text] [Related]
7. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.
Koylu MT; Kucukevcilioglu M; Erdurman FC; Durukan AH; Sobacı G; Torun D; Tunca Y; Ayyildiz O
Ophthalmic Genet; 2017; 38(4):352-356. PubMed ID: 28085519
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.
Gurgey A; Balta G; Boyvat A
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):121-4. PubMed ID: 12632020
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
12. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer.
Battistelli S; Stefanoni M; Genovese A; Vittoria A; Cappelli R; Roviello F
World J Gastroenterol; 2006 Jul; 12(26):4179-80. PubMed ID: 16830369
[TBL] [Abstract][Full Text] [Related]
14. Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations.
Ben-Ami R; Zeltser D; Leibowitz I; Berliner SA
Blood Coagul Fibrinolysis; 2002 Jan; 13(1):57-9. PubMed ID: 11994569
[TBL] [Abstract][Full Text] [Related]
15. The role of factor V Leiden and prothrombin G20210A mutations in sudden sensorineural hearing loss.
Görür K; Tuncer U; Eskandari G; Ozcan C; Unal M; Ozsahinoglu C
Otol Neurotol; 2005 Jul; 26(4):599-601. PubMed ID: 16015153
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
[TBL] [Abstract][Full Text] [Related]
17. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
Huber S; McMaster KJ; Voelkerding KV
J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
[TBL] [Abstract][Full Text] [Related]
18. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
[TBL] [Abstract][Full Text] [Related]
20. Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation.
Incorvaia C; Bandello F; Parmeggiani F; D'Angelo S; Costagliola C; Sebastiani A
Eur J Ophthalmol; 2002; 12(2):131-4. PubMed ID: 12022286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
